Replies to post #253314 on NorthWest Biotherapeutics Inc (NWBO)

[Umibe5690]

Marzan:

I have been saying that for a long, long time. Jumping 4x from $0.22 is $0.88. If they jack up the SP through well timed PRs, to say $0.30, you are in the $1.20 range and rather great for the Series B warrants expiring in April, 2020. The lack of transparency/silence has absolutely killed the stock and a low SP launching point would be extremely disappointing.

OTOH, if the results are impressive grand slam home runs, like for example, OS60 is 25%+, both original primary/secondary endpoints met, etc., it may make little difference where the launching SP is. In such a case, launch to over a dollar or two would be a good bet.

I think LP/LG understand all this much better than we MB denizens. They have a lot riding on this with all the shares they hold and potentially hold. No doubt they want to maximise value, even though they have pretty much de-risked. I think in this respect, their views are likely congruent with ours.

I am rather confident that results will be impressive, if not grand-slam homeruns. We could easily see a buck or more and upward from there. A lot of validation and much steeper slope for the naysayers who might still be there. Fingers crossed, but I think it is looking good. GLTU.